Completing data — usually done within a minute
Basic information
- CAS
63074-08-8- Standard SMILES
COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC.Cl- InChIKey
IWSWDOUXSCRCKW-UHFFFAOYSA-N- Molecular formula
- C19H26ClN5O4
- Average molar mass
- 423.9 g/mol
- Monoisotopic mass
- 423.16733199
Overview
See also: Terazosin (has active moiety); Terazosin Hydrochloride (annotation moved to).
Names & identifiers
- Preferred name
- Terazosin Hydrochloride Anhydrous
- IUPAC
- [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;hydrochloride
Names & synonyms
Show more names
Database identifiers
- CAS
63074-08-8、70024-40-7- PubChem CID
- 44383
- DTXSID
DTXSID7045493- ChEMBL
CHEMBL1256665- UNII
- 8QOP8Z9955
- EC Number
- 613-138-7
Properties
Computed structural propertiesFilling in
- Topological polar surface area
- 103 Ų
- Hydrogen bond donors
- 2
- Hydrogen bond acceptors
- 8
- Rotatable bonds
- 4
- Heavy atoms
- 29
- Formal charge
- 0
- Complexity
- 544
Experimental & physicochemical properties
Safety & regulation
GHS classification
GHS Classification
This chemical does not meet GHS hazard criteria for 25% (1 of 4) of reports.
Warning
H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]
P203, P264, P264+P265, P270, P280, P301+P317, P305+P351+P338, P318, P330, P337+P317, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 4 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard information
Chemistry & industry
Pharmacology
MeSH Pharmacological Classification
Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS.
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS.
Uses & manufacturing
Related reactions
Compound notes
Loading…